Krystal Biotech, a preclinical gene therapy biotech focused on dermatological diseases, raised $40 million by offering 3.96 million shares at $10, at the midpoint of the $9 to $11 target range. Insiders had indicated an interest in purchasing up to $5 million...read more
Seven deals are on the IPO calendar to raise a combined $1.6 billion in the week ahead. Chinese logistics provider Best leads the pack with an $869 million offering (the largest IPO of Q3), followed by leading Latin American...read more
Krystal Biotech, a preclinical gene therapy biotech focused on dermatological diseases, announced terms for its IPO on Thursday. The Pittsburgh, PA-based company plans to raise $30 million by offering 3.0 million shares at a price range of $9 to $11....read more
No US IPOs priced this week. Filing activity remained muted with one Chinese luxury e-commerce company, two micro-cap healthcare deals, and two tech-focused SPACs joining the pipeline, while another mico-cap biotech withdrew. With the...read more
Gene therapy micro-cap Krystal Biotech prices upsized $40 million IPO at $10 midpoint
Krystal Biotech, a preclinical gene therapy biotech focused on dermatological diseases, raised $40 million by offering 3.96 million shares at $10, at the midpoint of the $9 to $11 target range. Insiders had indicated an interest in purchasing up to $5 million...read more
US IPO Week Ahead: Most active week of the quarter with 7 IPOs, led by Alibaba-backed Best
Seven deals are on the IPO calendar to raise a combined $1.6 billion in the week ahead. Chinese logistics provider Best leads the pack with an $869 million offering (the largest IPO of Q3), followed by leading Latin American...read more
Gene therapy developer Krystal Biotech sets terms for $30 million IPO
Krystal Biotech, a preclinical gene therapy biotech focused on dermatological diseases, announced terms for its IPO on Thursday. The Pittsburgh, PA-based company plans to raise $30 million by offering 3.0 million shares at a price range of $9 to $11....read more
US IPO Weekly Recap: 5 new filings while summer slowdown in full effect
No US IPOs priced this week. Filing activity remained muted with one Chinese luxury e-commerce company, two micro-cap healthcare deals, and two tech-focused SPACs joining the pipeline, while another mico-cap biotech withdrew. With the...read more